Cercare Medical Receives FDA 510(k) Clearance for Cone-Beam CT Perfusion

Cercare Receives FDA Clearance for CBCT Perfusion and Collaborates With Siemens on Acute Stroke Care

May 29, 2026—Cercare Medical, a developer of neuroimaging software, announced FDA 510(k) clearance for the company’s Cone-Beam CT Perfusion (CBCT-P) solution, which is intended to enable qualitative perfusion assessment directly from cone-beam CT data acquired during neurointerventional procedures. The CBCT-P solution is based on Cercare Medical’s Vascular Model technology, which currently supports MRI and CT perfusion imaging, noted Cercare. Th…

Cercare Medical Receives FDA 510(k) Clearance for Cone-Beam CT Perfusion

The clearance marks an important step forward in acute stroke imaging by bringing advanced perfusion analysis directly into the angio suite, allowing clinicians to assess brain tissue in real time during and immediately after thrombectomy procedures The post Cercare Medical Receives FDA 510(k) Clearance for Cone-Beam CT Perfusion first appeared on Medical Device News Magazine.